Charles Hewitt Moore, FRCS (1821-1870): Medical innovator.

J Med Biogr

Borough of Manhattan Community College, CUNY, Department of English, NY, USA.

Published: August 2022

Charles Hewitt Moore, a Fellow of the Royal Society of Medicine, practiced at Middlesex and St. Luke's Hospitals and was administratively active in The Medical and Chirurgical Society. From 1851 to 1868, he demonstrated expertise in general surgery and the lymphatic system; on pelvic deformity and disease; on the vascular system and aneurisms; on the etiology of cancer; and on the neurophysiology of sleep. He subscribed to two principles of medical investigation: anomalies can reveal new information; and the propagation of untested theory inhibited medical learning and practice. Translator of the German edition of Rokitansky's (vol. 3, 1851), Moore wrote twelve papers, three chapters for Holmes' (1860-1862), and two treatises. Renowned in vascular and cancer surgery, he combined ablation with ZnCl against cutaneous and breast cancer. Theorizing that ganglionic nerve tissue was involved in the sleep cycle, he anticipated modern investigations into the sleep-related activity of basal ganglia, the only nerve tissue of that kind in the brain.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0967772020975021DOI Listing

Publication Analysis

Top Keywords

charles hewitt
8
hewitt moore
8
nerve tissue
8
moore frcs
4
frcs 1821-1870
4
medical
4
1821-1870 medical
4
medical innovator
4
innovator charles
4
moore fellow
4

Similar Publications

Effect of water pH and calcium on ion balance in five fish species of the Mekong Delta.

Comp Biochem Physiol A Mol Integr Physiol

June 2019

Department of Zoology, University of British Columbia, Vancouver, BC V6T 1Z4, Canada. Electronic address:

Acidic freshwater habitats disrupt ion-homeostasis in fishes, yet the often acidic waters of the Mekong host the second highest diversity of freshwater fish in the world. To investigate how five Mekong fish species tolerate water acidity, we measured: time to loss of equilibrium (LOE) at sustained (4 days) low pH (3.5) and net ion flux in acute low pH (3.

View Article and Find Full Text PDF

An enzyme-mediated assay to quantify inoculation volume delivered by suture needlestick injury: two gloves are better than one.

J Am Coll Surg

January 2008

Division of Surgical Research, Department of Surgery, Robert Wood Johnson Medical School, Cooper University Hospital, Camden, NJ 08103, USA.

Background: Acquiring a blood-borne disease is a risk of performing operations. Most data about seroconversion are based on hollow-bore needlesticks. Some studies have examined the inoculation volumes of pure blood delivered by suture needles.

View Article and Find Full Text PDF

Production of a novel fibroblast-populated platelet matrix cocultured with keratinocytes.

Tissue Eng

July 2007

Section of Trauma Surgical Critical Care and Surgical Emergencies, School of Medicine, Yale University, New Haven, Connecticut 06520, USA.

We have developed a new method for the production of a dermal matrix equivalent. Human platelets were used to dilute human fibroblasts. The platelet mix was placed in a cell culture well.

View Article and Find Full Text PDF

Noninvasive assessment of heterotopic heart transplants using Doppler echocardiography was first described in two patients by Allen at Stanford in 1981. Since then, numerous experiments studying heterotopic heart transplantation in humans and large animals have confirmed its utility by employing either an intra-abdominal or cervical model. In rats, however, prior research investigating intra-abdominal heterotopic hearts has showed echocardiography to be ineffective.

View Article and Find Full Text PDF

Review of vascularized bone marrow transplantation: current status and future clinical applications.

Microsurgery

September 2007

Division of Surgical Research, Department of Surgery, Robert Wood Johnson Medical School, Cooper University Hospital, Camden, NJ 08103, USA.

In this review, we examine the applicability of the vascularized bone marrow transplant (VBMT) as an alternative to conventional bone marrow transplantation (BMT). As a new surgical approach, the VBMT is unique by transplantation of the stromal environment that eliminates the need for an engraftment period, provides critical signaling and modulatory functions, and may potentiate tolerance induction. Thus far, VBMT studies have demonstrated an absence of graft-versus-host disease (GVHD) and robust engraftment into nonmanipulated as well as irradiated recipients with evidence of immunological tolerance.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!